A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michele Aizenberg, MD
University of Nebraska
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Henry Ford
Detroit, Michigan, United States
Ian Lee, MDNot, yet, recruiting - University of Nebraska Medical Center
Omaha, Nebraska, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Nov 2020
- Primary completion
- 31 Dec 2028
- Completion
- 31 Dec 2029
- Last update posted
- 28 Apr 2026
- Registered enrollment
- 100
- Registry id
- NCT04222062
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.